Number of items: 5.
2022
Tezcan, N., Özdemir-Kumral, Z. N., Özkan Yenal, N., Çilingir-Kaya, Ö. T., Virlan, A. T. , Özbeyli, D., Çetinel, Ş., Yeğen, B. Ç. and Koç, M.
(2022)
Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction.
Nephrology Dialysis Transplantation, 37(7),
pp. 1238-1248.
(doi: 10.1093/ndt/gfac053)
(PMID:35218196)
Kelly, L., McGrath, S., Rodgers, L., McCall, K., Tulunay Virlan, A. , Dempsey, F., Crichton, S. and Goodyear, C. S.
(2022)
Annexin-A1: the culprit or the solution?
Immunology, 166(1),
pp. 2-16.
(doi: 10.1111/imm.13455)
(PMID:35146757)
2018
Tom, B. D.M., Symmons, D. and RA-MAP Consortium:,
(2018)
Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data.
RMD Open, 4(2),
e000721.
(doi: 10.1136/rmdopen-2018-000721)
(PMID:30487994)
(PMCID:PMC6241979)
Elbasi, M. O., Tulunay Virlan, A. and Eksioglu Demiralp, E.
(2018)
Killer cell immunoglobulin-like receptor genotypes in the Turkish population.
Human Immunology, 79(4),
pp. 193-194.
(doi: 10.1016/j.humimm.2018.02.008)
(PMID:29454072)
2017
Deniz, R., Tulunay-Virlan, A. , Ture Ozdemir, F., Unal, A. U., Ozen, G., Alibaz-Oner, F., Aydin-Tatli, I., Mumcu, G., Ergun, T. and Direskeneli, H.
(2017)
Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet’s disease.
Immunological Investigations, 46(5),
pp. 518-525.
(doi: 10.1080/08820139.2017.1306865)
(PMID:28414558)
This list was generated on Mon May 29 19:56:54 2023 BST.